Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rui Lv

Showing results (181-190 of 202) with videos related to

Pageof 21
Sort By:
Oncogene|August 21, 2022
CEP63 upregulates YAP1 to promote colorectal cancer progression through stabilizing RNA binding protein FXR1Han Ling, Chen-Hui Cao, Kai Han, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 13, 2026
Integrating Radiomics and Computational Pathology to Predict Early Recurrence of Pancreatic Ductal Adenocarcinoma and Uncover Its Biological Basis in Tumor MicroenvironmentSihang Cheng, Fuze Cong, Shenbo Zhang, et al.
Molecular Medicine (Cambridge, Mass.)|February 3, 2025
NUAK1 acts as a novel regulator of PD-L1 via activating GSK-3β/β-catenin pathway in hepatocellular carcinomaChao-Yan Yao, Hang-Tian Tao, Jin-Jin He, et al.
Oncotarget|October 31, 2015
High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survivalShuhua Yi, Dehui Zou, Chengwen Li, et al.
Journal of Agricultural and Food Chemistry|December 17, 2024
Four-Dimensional Data-Independent Acquisition-Based Proteomic Profiling Combined with Transcriptomic Analysis Reveals the Involvement of the Slym1-SlFHY3-CAB3C Module in Regulating Tomato Leaf ColorPeiwen Wang, Ziheng Li, Lin Zhu, et al.
Oncotarget|February 10, 2018
Del17p does not always significantly influence the survival of B-cell chronic lymphoproliferative disordersShuhua Yi, Zengjun Li, Dehui Zou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2026
Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001)Wenqiang Yan, Chenxing Du, Rui Lv, et al.
Leukemia|August 2, 2024
Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myelomaWenqiang Yan, Lihui Shi, Jingyu Xu, et al.
Signal Transduction and Targeted Therapy|April 2, 2024
Mex-3 RNA binding family member A (MEX3A)/circMPP6 complex promotes colorectal cancer progression by inhibiting autophagyRi-Xin Chen, Shui-Dan Xu, Min-Hua Deng, et al.
Science (New York, N.Y.)|April 6, 2023
Lead zirconate titanate ceramics with aligned crystallite grainsJinglei Li, Wanbo Qu, John Daniels, et al.
Pageof 21

Showing results (181-190 of 202) with videos related to

Sort By:
Pageof 21
Oncogene|August 21, 2022
CEP63 upregulates YAP1 to promote colorectal cancer progression through stabilizing RNA binding protein FXR1Han Ling, Chen-Hui Cao, Kai Han, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 13, 2026
Integrating Radiomics and Computational Pathology to Predict Early Recurrence of Pancreatic Ductal Adenocarcinoma and Uncover Its Biological Basis in Tumor MicroenvironmentSihang Cheng, Fuze Cong, Shenbo Zhang, et al.
Molecular Medicine (Cambridge, Mass.)|February 3, 2025
NUAK1 acts as a novel regulator of PD-L1 via activating GSK-3β/β-catenin pathway in hepatocellular carcinomaChao-Yan Yao, Hang-Tian Tao, Jin-Jin He, et al.
Oncotarget|October 31, 2015
High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survivalShuhua Yi, Dehui Zou, Chengwen Li, et al.
Journal of Agricultural and Food Chemistry|December 17, 2024
Four-Dimensional Data-Independent Acquisition-Based Proteomic Profiling Combined with Transcriptomic Analysis Reveals the Involvement of the Slym1-SlFHY3-CAB3C Module in Regulating Tomato Leaf ColorPeiwen Wang, Ziheng Li, Lin Zhu, et al.
Oncotarget|February 10, 2018
Del17p does not always significantly influence the survival of B-cell chronic lymphoproliferative disordersShuhua Yi, Zengjun Li, Dehui Zou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2026
Phase II Study of BCMA Chimeric Antigen Receptor T-Cell Therapy in Patients With Newly Diagnosed Multiple Myeloma Ineligible for or Not Proceeding to Autologous Stem-Cell Transplantation (CAREMM-001)Wenqiang Yan, Chenxing Du, Rui Lv, et al.
Leukemia|August 2, 2024
Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myelomaWenqiang Yan, Lihui Shi, Jingyu Xu, et al.
Signal Transduction and Targeted Therapy|April 2, 2024
Mex-3 RNA binding family member A (MEX3A)/circMPP6 complex promotes colorectal cancer progression by inhibiting autophagyRi-Xin Chen, Shui-Dan Xu, Min-Hua Deng, et al.
Science (New York, N.Y.)|April 6, 2023
Lead zirconate titanate ceramics with aligned crystallite grainsJinglei Li, Wanbo Qu, John Daniels, et al.
Pageof 21